Glenmede Trust CO Na Bio Xcel Therapeutics, Inc. Transaction History

Glenmede Trust CO Na

  • $19.6 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$42.46 - $56.58 $102,965 - $137,206
-2,425 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$37.44 - $64.63 $23,212 - $40,070
620 Added 34.35%
2,425 $105,000
Q2 2020

Aug 14, 2020
BUY
$17.62 - $58.71 $31,804 - $105,971
1,805 New
1,805 $95,000

Others Institutions Holding BTAI

# of Institutions
78
Shares Held
7.26M
Call Options Held
101K
Put Options Held
205K
View Full List

About BioXcel Therapeutics, Inc.

BTAI Quotes by TradingView
  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $16.8M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email